Financial Statements — BACQU
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 |
|---|
| Cash & Equivalents | 183.55 | 125.35 | 1.05 | 1.75 | 1.87 | -- |
| Short-term Investments | 0.32 | 0.33 | -- | -- | -- | -- |
| Accounts Receivable | 1.76 | 1.34 | -- | -- | -- | -- |
| Total Current Assets | 191.02 | 130.01 | 1.33 | 1.98 | 2.13 | 0.00 |
| Property, Plant & Equipment | 11.23 | 10.29 | -- | -- | -- | -- |
| Total Non-current Assets* | 13.28 | 15.36 | 259.75 | 257.11 | 254.50 | 0.29 |
| Total Assets | 206.98 | 145.38 | 261.07 | 259.09 | 256.63 | 0.30 |
| Accounts Payable | 5.88 | 6.86 | -- | -- | -- | -- |
| Short-term Debt | 0.00 | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.02 | 14.91 | 3.12 | 1.22 | 1.08 | -- |
| Long-term Debt | 0.00 | 32.06 | -- | -- | -- | -- |
| Total Non-current Liabilities* | 131.39 | 89.25 | 8.75 | 8.75 | 8.75 | -- |
| Total Liabilities | 144.41 | 104.16 | 11.87 | 9.97 | 9.82 | 0.35 |
| Retained Earnings | (699.90) | (641.47) | (10.53) | (7.93) | (7.59) | (0.08) |
| Total Stockholder Equity | (99.93) | (139.11) | (10.53) | (7.93) | (7.58) | (0.05) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 |
|---|
| Total Revenue | 2.19 | 1.00 | -- | -- | 3.11 | -- | -- |
| Cost of Revenue | 2.09 | 1.64 | -- | -- | -- | -- | -- |
| Gross Profit | (0.12) | 1.81 | -- | -- | -- | -- | -- |
| Research & Development | 16.39 | 14.09 | -- | -- | -- | -- | -- |
| Selling, General & Admin | 15.58 | 14.09 | 0.64 | 2.62 | 0.36 | 0.24 | -- |
| Total Operating Expenses | 33.42 | 28.83 | -- | -- | -- | -- | -- |
| Operating Income | (33.54) | (27.01) | (0.64) | (2.62) | (0.36) | (0.24) | (0.08) |
| Pretax Income | (58.30) | (90.37) | -- | -- | -- | -- | -- |
| Tax Provision | 0.13 | 0.05 | -- | -- | -- | -- | -- |
| Net Income | (58.43) | (90.42) | 1.20 | 0.08 | 2.31 | 2.42 | (0.08) |
| Basic EPS | (1.40) | (1.27) | -- | -- | -- | -- | -- |
| Diluted EPS | (1.40) | (1.27) | -- | -- | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Operating Cash Flow | (27.25) | (23.64) | (0.27) | (0.70) | (0.12) | (0.24) |
| Capital Expenditures | 1.66 | 2.16 | -- | -- | -- | -- |
| Free Cash Flow* | (28.91) | (25.80) | -- | -- | -- | -- |
| Investing Cash Flow | (1.66) | (2.16) | -- | -- | -- | -- |
| Financing Cash Flow | 89.69 | 91.81 | -- | -- | -- | -- |
* Derived from reported values
